A SPECIFIC, SENSITIVE RADIOIMMUNOASSAY FOR PLATELET-ACTIVATING FACTOR (PAF)

被引：28
|
作者：
SMAL, MA
BALDO, BA
MCCASKILL, A
机构：
[1] ROYAL N SHORE HOSP,KOLLING INST MED RES,ST LEONARDS,NSW 2065,AUSTRALIA
[2] SILENUS LABS PTY LTD,HAWTHORN,VIC 3122,AUSTRALIA
[3] UNIV SYDNEY,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA
来源：
JOURNAL OF IMMUNOLOGICAL METHODS | 1990年 / 128卷 / 02期
关键词：
Anti-platelet-activating factor; Platelet-activating factor; Platelet-activating factor radioimmunoassay; Quantitation of platelet-activating factor;
D O I：
10.1016/0022-1759(90)90209-E
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
A specific radioimmunoassay (RIA) has been developed for platelet-activating factor (PAF) and shown to be sensitive over the range 10-1000 pg (0.02-2 pmol). The anti-PAF antibodies showed specificity for the acetyl group at the C2 position of the PAF molecule and exhibited no significant cross-reactivity with lyso-PAF or the naturally occurring lipids including lecithin and lysolecithin. The sensitivity of the RIA was at least as good as the platelet-based assays for PAF but the RIA was simpler to perform, had a higher capacity and did not have the drawback of the inherent variability associated with the bioassays. © 1990.
引用
收藏
页码：183 / 188
页数：6
相关论文
共 50 条
  • [21] Platelet-activating factor (PAF) acts as an autocrine capacitation factor.
    O'Neill, C
    Wu, CJ
    Stojanov, T
    BIOLOGY OF REPRODUCTION, 2000, 62 : 217 - 218
  • [22] A SYNTHETIC PHOSPHOLIPID INHIBITOR OF PLATELET-ACTIVATING FACTOR (PAF) BIOSYNTHESIS
    ROBBINS, JC
    MACHOY, BH
    LAM, MH
    PONPIPOM, MM
    RUPPRECHT, KM
    SHEN, TY
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1269 - 1269
  • [23] DESENSITIZATION OF HUMAN-PLATELETS BY PLATELET-ACTIVATING FACTOR (PAF)
    CHESNEY, CM
    PIFER, DD
    HUCH, KM
    FEDERATION PROCEEDINGS, 1984, 43 (04) : 977 - 977
  • [24] PLATELET-ACTIVATING FACTOR (PAF-ACETHER) - PRESENT STATUS
    BENVENISTE, J
    AGENTS AND ACTIONS, 1981, 11 (6-7): : 542 - 544
  • [25] EFFECT OF PLATELET-ACTIVATING FACTOR (PAF) ON HUMAN-PLATELETS
    CHESNEY, CM
    PIFER, DD
    BYERS, LW
    MUIRHEAD, EE
    BLOOD, 1982, 59 (03) : 582 - 585
  • [26] ENZYMATIC ASSEMBLY OF PLATELET-ACTIVATING FACTOR (PAF-ACETHER)
    MENCIAHUERTA, JM
    NINIO, E
    LANDES, A
    GODFROID, JJ
    BENVENISTE, J
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 1015 - 1015
  • [27] Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist
    Bagnis, C
    Deray, G
    Dubois, M
    Pirotzky, E
    Jacquiaud, C
    Baghos, W
    Aupetit, B
    Braquet, P
    Jacobs, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (03) : 507 - 513
  • [28] RELEASE OF PLATELET-ACTIVATING FACTOR (PAF) BY MACROPHAGES DURING PHAGOCYTOSIS
    BENVENISTE, J
    MENCIAHUERTA, JM
    FEDERATION PROCEEDINGS, 1978, 37 (06) : 1554 - 1554
  • [29] STRUCTURAL ANALOGS OF PLATELET-ACTIVATING FACTOR (PAF-ACETHER)
    TENCE, M
    COEFFIER, E
    HEYMANS, F
    POLONSKY, J
    GODFROID, JJ
    BENVENISTE, J
    BIOCHIMIE, 1981, 63 (8-9) : 723 - 727
  • [30] Inflammatory actions of platelet-activating factor: Control by PAF acetylhydrolase
    Prescott, SM
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 1997, 7 (05): : 416 - 416
12345